Septerna (SEPN) Change in Receivables (2023 - 2026)
Septerna's (SEPN) quarterly Change in Receivables came in at $486000.0 in Q1 2026, up 515.19% year-on-year from $79000.0 in Q1 2025, and down 71.6% quarter-over-quarter from $1.7 million in Q4 2025.
Septerna (SEPN) Change in Receivables (2023 - 2026) Analysis & Trends
Septerna's Change in Receivables history runs 4 years deep, the most recent figure standing at $486000.0 for Q1 2026.
- On a quarterly basis, Change in Receivables rose 515.19% year-over-year to $486000.0 in Q1 2026; TTM through Mar 2026 was $10.6 million, a 7612.06% increase from a year earlier, with the FY2025 full-year figure at $10.2 million, up 50825.0% from the prior year.
- Change in Receivables eased to $486000.0 in Q1 2026 per SEPN's latest filing, from $1.7 million in the prior quarter.
- Across five years, Change in Receivables topped out at $8.5 million in Q3 2025 and bottomed at -$190000.0 in Q2 2024.
- The 4-year median for Change in Receivables is $98500.0 (2023), against an average of $1.1 million.
- Across the five-year window, Change in Receivables slumped 133.9% in 2024 and jumped 84840.0% in 2025, its largest moves.
- Year by year, Change in Receivables stood at $118000.0 in 2023, then slumped by 133.9% to -$40000.0 in 2024, then soared by 4377.5% to $1.7 million in 2025, then tumbled by 71.6% to $486000.0 in 2026.
- Per Business Quant, the three latest SEPN Change in Receivables figures stand at $486000.0 (Q1 2026), $1.7 million (Q4 2025), and $8.5 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Septerna | 1.50 Bn | 1.50 Bn | - | 486,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 486,000.00 |
| Mar 31, 2026 | 486,000.00 |
| Dec 31, 2025 | 1.71 Mn |
| Dec 31, 2025 | 1.71 Mn |
| Sep 30, 2025 | 8.49 Mn |
| Sep 30, 2025 | 8.49 Mn |
| Jun 30, 2025 | -99,000.00 |
| Jun 30, 2025 | -99,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Jun 30, 2024 | -190,000.00 |
| Jun 30, 2024 | -190,000.00 |
| Mar 31, 2024 | 240,000.00 |
| Mar 31, 2024 | 240,000.00 |
| Dec 31, 2023 | 118,000.00 |
| Dec 31, 2023 | 118,000.00 |